Ireland
--:--IST
Latest
Clinical Trials in France / NCT05108948
Recruiting Observational

Research of Factors Determining the Improvement of Quality of Life at One Year of Adult Patients Treated for Spinal Deformity (COFTASD)

NCT05108948 · tracked via the Priya Life Science France tracker
Sponsor
Phase
Observational
Started
2021-10-23
Last updated
2024-02-29

Condition(s) studied

Spinal Deformity

Investigational drug(s) / intervention(s)

Quality of life questionnairesRadiography

Quality of life questionnaires: Oswestry Disability Index Scoliosis Research Society-22R Short Form 36 Health Survey Questionnaire Tobacco, Alcohol, Prescription medication, and other Substance use Core Outcome Measures Index : back and neck

Radiography: Spinal radiography : full, face, profile

Study summary

The objective of this study is to find the predictive factors of improvement of the quality of life of operated patients from spinal deformity.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age over 18 years-old * Diagnosis of Adult Spinal Deformity with any of the deformity characteristics following: * Scoliosis with a Cobb angle ≥ 20 ° * Vertical sagittal axis (SVA) ≥ 5 cm * Pelvic tilt ≥25 °, * Thoracic kyphosis with a Cobb angle ≥ 60 ° * Eligible for surgery * Having given their participation agreement * Affiliate or beneficiary of a social security scheme Exclusion Criteria: * Age under 18 years-old * Patient unlikely to comply with follow-up * Patient with long-term complete paraplegia * Patient unable to understand and answer questionnaires in due to language difficulties or cognitive impairment * Pregnant or breastfeeding woman * Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Clinique du dos Bruges France Recruiting

More Elsan trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05108948 on ClinicalTrials.gov ↗ ← All trials in France